Target intelligence / Profile preview

Candidatus Falsirhodobacter halotolerans DnaE split intein (Cfa split intein) (Cfa split intein)

Target
Cfa split intein
Molecular classification
Enzyme, Protein-splicing element, Molecular tool
01

Overview

The Cfa split intein is a highly efficient protein-splicing element derived from the DnaE polymerase of the bacterium Candidatus Falsirhodobacter halotolerans (Stevens, A. J., et al., 2017, JACS). It is composed of two separate polypeptides, the N-terminal (CfaN) and C-terminal (CfaC) fragments, which possess a high affinity for one another and undergo spontaneous reassembly. Once assembled, the intein catalyzes its own excision while simultaneously joining the flanking protein sequences, known as exteins, with a native peptide bond through a process called protein trans-splicing (PTS). This intein is particularly valued in biotechnology due to its exceptional splicing speed, high yields, and robustness across various temperatures and buffer conditions. It is frequently employed in synthetic biology and gene therapy to circumvent size limits of delivery vectors, such as Adeno-associated viruses (AAV), by splitting large therapeutic proteins like Cas9 into two parts that reconstitute functionally within the target cell (Li, J., et al., 2021, Communications Biology). While not a traditional drug target, its role as a molecular tool is critical for developing next-generation biologics and precision medicines.

Other names
CfaN/CfaCCfa DnaE inteinFalsirhodobacter halotolerans split inteinCfa split intein N- and C-fragments
02

Mechanism of action

Protein trans-splicing (PTS) involving four nucleophilic displacement steps to ligate flanking exteins.

03

Biological functions

Protein trans-splicingAutocatalytic protein processingPost-translational modification
04

Disease associations

Other
05

Safety considerations

Immunogenicity in human applicationsPotential for non-specific splicingEfficiency variations in different cellular environments

Beyond the preview

Go deeper on Candidatus Falsirhodobacter halotolerans DnaE split intein (Cfa split intein) (Cfa split intein).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candidatus Falsirhodobacter halotolerans DnaE split intein (Cfa split intein) (Cfa split intein).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call